162 related articles for article (PubMed ID: 25549141)
21. An update on the application of newly described immunohistochemical markers in soft tissue pathology.
Lin G; Doyle LA
Arch Pathol Lab Med; 2015 Jan; 139(1):106-21. PubMed ID: 25549147
[TBL] [Abstract][Full Text] [Related]
22. Application of immunohistochemistry in thyroid pathology.
Liu H; Lin F
Arch Pathol Lab Med; 2015 Jan; 139(1):67-82. PubMed ID: 25549145
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemistry in undifferentiated neoplasm/tumor of uncertain origin.
Lin F; Liu H
Arch Pathol Lab Med; 2014 Dec; 138(12):1583-610. PubMed ID: 25427040
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
[TBL] [Abstract][Full Text] [Related]
25. Use of tissue microarrays and immunohistochemistry to standardize the diagnosis of gastrointestinal stromal tumors.
Ogino J; Asanuma H; Sakurai S; Matsuno Y; Miyokawa N; Yamashiro K; Fukazawa Y; Muraoka S; Iwaki Y; Kondo N; Hasegawa T
Pathol Int; 2010 Nov; 60(11):707-13. PubMed ID: 20946519
[TBL] [Abstract][Full Text] [Related]
26. Application of Immunohistochemistry in Undifferentiated Neoplasms: A Practical Approach.
Kandukuri SR; Lin F; Gui L; Gong Y; Fan F; Chen L; Cai G; Liu H
Arch Pathol Lab Med; 2017 Aug; 141(8):1014-1032. PubMed ID: 28745568
[TBL] [Abstract][Full Text] [Related]
27. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
[TBL] [Abstract][Full Text] [Related]
28. BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid Rodolico V; Cabibi D; Pizzolanti G; Richiusa P; Gebbia N; Martorana A; Russo A; Amato MC; Galluzzo A; Giordano C
Cancer; 2007 Sep; 110(6):1218-26. PubMed ID: 17685465
[TBL] [Abstract][Full Text] [Related]
29. [Liver cancer: immunohistochemical and electron microscopic study].
Raĭkhlin NT; Gurevich LE; Smirnova MA; Shabanov MA; Sagaĭdak IV; Ustinov EI; Korsakova NA; Chistiakova OV; Gakhramanov AD
Arkh Patol; 2006; 68(6):10-2. PubMed ID: 17290885
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathology and molecular diagnostics of gastrointestinal stromal tumors.
Lucas DR
Curr Probl Cancer; 2011; 35(5):233-44. PubMed ID: 22118563
[No Abstract] [Full Text] [Related]
31. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Cervera P; Fléjou JF
Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
[TBL] [Abstract][Full Text] [Related]
32. Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases.
La Rosa S; Marando A; Gatti G; Rapa I; Volante M; Papotti M; Sessa F; Capella C
Hum Pathol; 2013 Jul; 44(7):1391-9. PubMed ID: 23375646
[TBL] [Abstract][Full Text] [Related]
33. Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer.
Asioli S; Maletta F; Verdun di Cantogno L; Satolli MA; Schena M; Pecchioni C; Botta C; Chiusa L; Molinaro L; Conti L; Viale G; Ingravallo G; Maiorano E; Sapino A
Hum Pathol; 2012 Nov; 43(11):2070-9. PubMed ID: 22658277
[TBL] [Abstract][Full Text] [Related]
34. Brain metastases of gastro-oesophageal cancer: evaluation of molecules with relevance for targeted therapies.
Preusser M; Berghoff AS; Ilhan-Mutlu A; Dinhof C; Magerle M; Marosi C; Hejna M; Capper D; VON Deimling A; Schoppmann SF; Birner P
Anticancer Res; 2013 Mar; 33(3):1065-71. PubMed ID: 23482783
[TBL] [Abstract][Full Text] [Related]
35. Pathology--trends and pitfalls in histologic diagnosis, immunopathology, and applications of oncogene research.
Burger PC; Fuller GN
Neurol Clin; 1991 May; 9(2):249-71. PubMed ID: 1682793
[TBL] [Abstract][Full Text] [Related]
36. The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas.
Rossi G; Graziano P; Leone A; Migaldi M; Califano R
Semin Diagn Pathol; 2013 Nov; 30(4):298-312. PubMed ID: 24342286
[TBL] [Abstract][Full Text] [Related]
37. Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors.
Zhu S; Schuerch C; Hunt J
Arch Pathol Lab Med; 2015 Jan; 139(1):55-66. PubMed ID: 25549144
[TBL] [Abstract][Full Text] [Related]
38. Application of immunohistochemistry in breast pathology: a review and update.
Liu H
Arch Pathol Lab Med; 2014 Dec; 138(12):1629-42. PubMed ID: 25427042
[TBL] [Abstract][Full Text] [Related]
39. Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful?
Shen SS; Truong LD; Scarpelli M; Lopez-Beltran A
Arch Pathol Lab Med; 2012 Apr; 136(4):410-7. PubMed ID: 22458903
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry and molecular diagnostics of pleural malignant mesothelioma.
Betta PG; Magnani C; Bensi T; Trincheri NF; Orecchia S
Arch Pathol Lab Med; 2012 Mar; 136(3):253-61. PubMed ID: 22372901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
